BSN medical Launches Six New Products -- Three With Its Proprietary DACC Technology at SAWC Spring

CHARLOTTE, NC--(Marketwired - May 1, 2015) - BSN medical, a leading global medical device manufacturer, announced today the launch of six new wound care products, including three with the company's unique DACC (dialkylcarbamoylchloride) Technology, a powerful alternative to silver antimicrobial dressings for wound healing. The suite of new wound care solutions are being showcased in booth #225 at the Symposium on Advanced Wound Care (SAWC Spring) in San Antonio, Tex.

BSN medical's DACC Technology "catches" or binds bacteria, rendering it inert and reducing the bacteria load in the wound bed. By catching the bacteria versus killing it helps to keep the bacteria cell wall intact, which allows for fast, effective natural healing. Of the six products BSN medical is launching, three new wound-healing dressings include its pioneering DACC technology.

• The Cutimed® Sorbact® Hydroactive B dressing is designed for effective fluid management on wounds with low to moderate exudate levels. This hydropolymer gel dressing combines absorbency with balanced hydration plus DACC Technology for fast, effective wound healing.
• The Cutimed Siltec Sorbact is an innovative foam dressing that combines DACC technology with Siltec foam structure so it can rapidly absorb and draw fluid into super absorbent particles for less risk of peri-wound maceration. The foam dressing is designed for any type of wound with moderate to high exudate levels.
• The Leukomed® Sorbact is a post-operative dressing with the wound contact layer (WCL) coated with DACC Technology so it safely and effectively binds bacteria and fungi without a chemically active agent. This minimizes the risk of infection and maintains a favorable healing environment.
  
  

"BSN medical's DACC Technology addresses multiple complexities found in a variety of chronic wounds because it treats both topical wounds and the underlying cause," said Catherine Milne, RN, Co-owner of Connecticut Clinical Nursing Associates in Bristol, Conn. "We use the dressings coated with DACC Technology to manage the bioburden, which often attributes to the slow healing process. In addition, because the DACC Technology does not release any chemical agents to fight the bacteria or fungi, as we have found in other antimicrobial products available today, it is a more desirable and effective wound healing treatment option for highly colonized or infected wounds. In addition, we've found that patients heal more rapidly when we apply dressings with DACC Technology."

The company also announced that two accepted clinical posters highlighting the healing effectiveness of DACC Technology compared to silver, as well as an industry-sponsored breakfast symposium today at 7:30 am are part of the SAWC 2015 program. The breakfast symposium, a CME, CNE, CPME accredited meeting, will study the use of DACC Technology and Total Contact Casting as an integrated treatment pathway for treating diabetic foot ulcers and implications of silver resistance.

One poster, entitled, "DACC and NPWT: A Combination to Treat Complex Wounds" by Keum-Lee Mayes, RN, looks at the combined treatment of negative pressure wound therapy and an antimicrobial agent to assist in reducing the bacterial load and manage infection in a variety of complex acute and chronic wounds. She evaluates DACC Technology as an alternative to silver products in conjunction with NPWT to manage the bioburden, infection and achieve healing results. Initial results show that complex wounds were managed more effectively with DACC Technology and NPWT vs. NPWT alone or in combination with a silver product.

A second poster, "Plasmid-Mediated Silver Resistance Identified in Clinically Isolated Enterobacteriaceae: Major Implications for Burn and Wound Care," by Phillip J. Finley, Ph.D. et al., studies silver-based burn and wound dressings, and the resulting silver resistance emerging in clinical bacteria. Early results show that first clinical bacteria identified to display clinically significant silver resistance with a need for increased antimicrobial stewardship. In addition, findings show that DACC Technology has the ability to bind highly silver-resistant bacteria.

"These findings in the two posters suggest that the use of BSN medical's DACC Technology is an effective alternative to silver products in the removal of bacteria from wound beds, managing bacterial resistance and preventing further infection for faster wound healing," said Linda LaMagna, senior vice president, Wound Care Vascular, BSN medical. "The growing research and studies underway utilizing DACC Technology further exemplify its significant role in the removal of bacteria from wound beds allowing for natural healing, and that it may be used throughout the healing process to prevent infections across the wound care continuum."

About BSN medical
BSN medical is a global leader in the worldwide healthcare market specializing in the areas of Wound Care and non-invasive Vascular solutions including Compression Therapy, and Orthopedics including Fracture Management and Soft Goods. The company is focused on the development of world-class branded products that offer high quality solutions for patients and caregivers alike. BSN medical has a global reach through its 35 international operating companies and its network of trusted partners in many markets. The company, with headquarters in Hamburg, Germany, has 5,500 employees worldwide.